Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition

13 Jun 2005 07:00

Torex Retail PLC13 June 2005 13 June 2005 TOREX RETAIL PLC CONTINUED EXPANSION OF EUROPEAN BUSINESS WITH €4.25 MILLION ACQUISITION OF LEADING GERMAN RETAIL WORKFORCE MANAGEMENT SYSTEMS SUPPLIER Torex Retail Plc ("Torex Retail" or "the Group"), the leading internationalsystems supplier, is pleased to announce that it has acquired HoffmannDatentechnik GmbH ("Hoffmann" or "the Company") for a total consideration of€4.25 million. This consideration will be satisfied by the payment of €2.50million in cash and €1.75 million by the issue of 1,146,465 new Torex Retailordinary shares payable on completion. Hoffmann is the leading supplier of workforce management and labour schedulingsystems to the German retail market. The Company has a base of over 2,500installed systems in some 300 customers in Germany, Switzerland, Austria,Belgium, Poland, Romania and the Czech Republic. The strong customer basecomprises some of Germany's largest retailers including Praktiker (Metro),Globus (Rewe), IKEA, Toys'R'Us, Douglas and EDKA. Hoffmann is based in near Bremen and in the year ended 31 December 2004 theCompany achieved revenues of €2.5 million. Chris Moore, Chief Executive of Torex Retail commented: "Hoffmann is a longstanding and well respected supplier to the European retailmarket. For a small business it has a fantastic blue chip customer base whichbears testimony to the strength of its product set and reputation for customerservice. We are already the market leader in the UK in labour scheduling with customerslike Tesco taking our solution and Hoffmann greatly increases our capabilityacross Europe. The acquisition will give rise to significant cross sellingopportunities in the German market and also provides a product which can be soldthroughout our business, including to the large US market." Application will be made for the 1,146,465 new shares to be issued pursuant tothe consideration for the acquisition to be admitted to trading on AIM.Admission is expected to become effective on 16 June 2005. Ends. Enquiries: Torex Retail plc 0870 050 9900Chris Moore, Chief ExecutiveRichard Thompson, Finance Director Citigate Dewe Rogerson 020 7638 9571Ginny Pulbrook / Seb Hoyle About Torex Retail plc Torex Retail is a leading independent provider of cutting edge retail technologysolutions to many of the world's principal retailers. Since the company'sflotation in spring 2004 Torex Retail has achieved rapid growth across all ofits markets and has rigorously pursued its goal of becoming the provider ofchoice. As a result, the company now has a presence in all of the major marketsaround the world and has built a strong platform for future growth in line withits strategy. Torex's Retail's product and solution set spans high street andout-of-town retail as well as the petroleum and convenience sector and with over2,000 blue-chip customer relationships, including Tesco, Woolworth, Selfridges,Shell and Argos, the company has earned a leading reputation amongst retailers.Torex Retail has more than 1,000 staff based across the UK, Europe, South-EastAsia and the United States. www.torexretail.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Mar 20157:09 amRNSDermaPure gains Medicare coverage approval
5th Mar 20151:36 pmRNSIssue of equity and total voting rights
5th Mar 20151:18 pmRNSIssue of equity and total voting rights
5th Mar 201510:38 amRNSUK Patient has world's first OrthoPure XM implant
26th Feb 201510:43 amRNSResignation of Dr Alison Fielding
9th Feb 201512:05 pmRNSResult of General Meeting
4th Feb 201510:59 amRNSIssue of equity and total voting rights
22nd Jan 201511:13 amRNSResults of Placing
22nd Jan 20157:00 amRNSProposed placing of new Ordinary Shares
1st Dec 20149:45 amRNSHolding(s) in Company
28th Nov 20149:45 amRNSHolding(s) in Company
25th Nov 20148:15 amRNSNotice of allowance for US meniscus patent
5th Nov 20147:00 amRNSTissue Regenix gains Medicare and Medicaid Q code
29th Oct 20147:00 amRNSInterim Results
22nd Oct 20149:01 amRNSInterim Results and Capital Markets Day
20th Oct 201410:19 amRNSdCELL(R) presented at prestigious EACTS congress
17th Oct 20143:35 pmRNSInitial Clinical Trial Results
10th Sep 20149:00 amRNSdCELL® technology presented at Royal Society event
30th Jul 20147:00 amRNSUK meniscus clinical trial & DermaPure US updates
25th Jul 20147:00 amRNSTissue Regenix adds European bladder matrix patent
18th Jul 201411:11 amRNSIssue of equity and total voting rights
27th Jun 20143:06 pmRNSResult of AGM
12th Jun 20147:00 amRNSTissue Regenix announces launch of DermaPure in US
22nd May 20147:00 amRNSPreliminary Decision to Approve "Q" Code Request
20th May 20147:00 amRNSDeferred Annual Bonus Award
19th May 201410:21 amRNSAnnual Report & Accounts and Notice of AGM
19th May 20147:00 amRNSPreliminary results for year ended 31 January 2014
16th May 20141:00 pmRNSTissue Regenix adds US patent
12th May 201411:00 amRNSNotice of Preliminary Results
30th Apr 20145:14 pmRNSHolding(s) in Company
28th Apr 20147:00 amRNSTissue Regenix adds Chinese patent
24th Apr 20148:40 amRNSHolding(s) in Company
4th Feb 20143:03 pmRNSIssue of Share Options
31st Jan 20141:11 pmRNSHolding(s) in Company
14th Jan 20145:22 pmRNSIssue of equity and total voting rights
9th Jan 201411:11 amRNSIssue of equity and total voting rights
19th Dec 20137:00 amRNSTissue Regenix to attend JPMorgan Healthcare Event
12th Dec 20137:00 amRNSTissue Regenix signs US distribution agreements
22nd Nov 20137:00 amRNSDirector Share Purchase
29th Oct 20137:00 amRNSPresentation at Proactiveinvestors Forum in Dublin
28th Oct 20134:49 pmRNSDirector Share Purchase
21st Oct 20137:00 amRNSPublication of DermaPure UK trial results
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
14th Oct 20137:00 amRNSTissue Regenix USA successful technology transfer
8th Oct 20137:00 amRNSInterim Results for six months ended 31 July 2013
12th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Marketing
6th Aug 20139:41 amRNSHolding(s) in Company
5th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.